# FDA recall D-0884-2022

> **Cardinal Health Inc.** · Class II · drug recall initiated 2022-04-05.

## Product

Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only,  Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80

## Reason for recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions

## Distribution

NM only

## Key facts

- **Recall number:** D-0884-2022
- **Recalling firm:** Cardinal Health Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2022-04-05
- **Report date:** 2022-05-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dublin, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0884-2022

## Citation

> AI Analytics. FDA recall D-0884-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0884-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*